Sponsor or institution
Clinical trials and research at Shanghai Huaota Biopharmaceutical Co., Ltd.
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Shanghai Huaota Biopharmaceutical Co., Ltd. that are recruiting, at sites in 2 countries (most in China (6), United States (1)). 2 were first registered in the last 30 days. By phase: Phase 1/2 (3), Phase 3 (1), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2New in 30 days
- 2Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| HB0025 with chemotherapy as first-line treatment for advanced or recurrent endometrial cancer | Phase 3 | Guangzhou, Guangdong and 1 other locations | Recruiting | Oct 29, 2026 |
| HB0056 in adults with moderate to severe asthma | Phase 1/2 | Beijing and 1 other locations | Recruiting | Oct 28, 2026 |
| Evaluating HB0043 for treating Hidradenitis Suppurativa | Phase 1/2 | Jinan, Shandong | Recruiting | Mar 26, 2025 |
| Evaluating HB0034 in healthy Chinese adults | Phase 1 | Jinan, Shandong | Recruiting | Dec 4, 2024 |
| Evaluating HB0034 for treating severe flares of generalized pustular psoriasis | Phase 2 | Beijing and 1 other locations | Recruiting | Jan 30, 2024 |
| Evaluating HB0036 for advanced solid tumors | Phase 1/2 | Lafayette, Indiana and 3 other locations | Recruiting | Jun 14, 2022 |
All recruiting trials (6)
-
HB0025 with chemotherapy as first-line treatment for advanced or recurrent endometrial cancer
This study tests whether adding HB0025 to standard chemotherapy helps patients with advanced or recurrent pMMR endometrial cancer succeed more than chemotherapy alone.
-
HB0056 in adults with moderate to severe asthma
This study tests HB0056 versus a placebo to see if it helps adults with moderate to severe asthma reduce rescue inhaler use and improve symptoms.
-
Evaluating HB0043 for treating Hidradenitis Suppurativa
This study is testing a new treatment called HB0043 to see if it helps adults with moderate to severe Hidradenitis Suppurativa feel better and stay safe during the process.
-
Evaluating HB0034 in healthy Chinese adults
This study tests if the new drug HB0034 is safe for healthy Chinese adults by giving them different doses and comparing it to a placebo.
-
Evaluating HB0034 for treating severe flares of generalized pustular psoriasis
This study is testing if a new treatment called HB0034 can help people with severe flare-ups of generalized pustular psoriasis feel better.
-
Evaluating HB0036 for advanced solid tumors
This study is testing a new treatment called HB0036 to see if it is safe and effective for people with advanced solid tumors, including non-small cell lung cancer.
Quick answers
How many clinical trials run by Shanghai Huaota Biopharmaceutical Co., Ltd. are recruiting right now?
6, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (6 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 3: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.